Your browser doesn't support javascript.
loading
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
Cline, Melissa S; Liao, Rachel G; Parsons, Michael T; Paten, Benedict; Alquaddoomi, Faisal; Antoniou, Antonis; Baxter, Samantha; Brody, Larry; Cook-Deegan, Robert; Coffin, Amy; Couch, Fergus J; Craft, Brian; Currie, Robert; Dlott, Chloe C; Dolman, Lena; den Dunnen, Johan T; Dyke, Stephanie O M; Domchek, Susan M; Easton, Douglas; Fischmann, Zachary; Foulkes, William D; Garber, Judy; Goldgar, David; Goldman, Mary J; Goodhand, Peter; Harrison, Steven; Haussler, David; Kato, Kazuto; Knoppers, Bartha; Markello, Charles; Nussbaum, Robert; Offit, Kenneth; Plon, Sharon E; Rashbass, Jem; Rehm, Heidi L; Robson, Mark; Rubinstein, Wendy S; Stoppa-Lyonnet, Dominique; Tavtigian, Sean; Thorogood, Adrian; Zhang, Can; Zimmermann, Marc; Burn, John; Chanock, Stephen; Rätsch, Gunnar; Spurdle, Amanda B.
Afiliação
  • Cline MS; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Liao RG; Broad Institute, Cambridge, Massachusetts, United States of America.
  • Parsons MT; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Paten B; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
  • Alquaddoomi F; Department of Computer Science, Biomedical Informatics Group Universitätsstrasse, Zürich, Switzerland.
  • Antoniou A; Biomedical Informatics, University Hospital Zurich, Zurich, Switzerland.
  • Baxter S; Biocybernetics Laboratory, Computer Science Department, University of California, Los Angeles, California, United States of America.
  • Brody L; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Cook-Deegan R; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
  • Coffin A; Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, Bethesda, Maryland, United States of America.
  • Couch FJ; School for the Future of Innovation in Society, and Consortium for Science, Policy & Outcomes, Arizona State University, Tempe, Arizona, United States of America.
  • Craft B; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Currie R; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Dlott CC; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Dolman L; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • den Dunnen JT; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Dyke SOM; The Global Alliance for Genomics and Health, Toronto, Ontario, Canada.
  • Domchek SM; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Easton D; Centre of Genomics and Policy, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
  • Fischmann Z; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Foulkes WD; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
  • Garber J; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Goldgar D; Program in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, Quebec, Canada.
  • Goldman MJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Goodhand P; Huntsman Cancer Institute and Department of Dermatology, University of Utah, Salt Lake City, Utah, United States of America.
  • Harrison S; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Haussler D; The Global Alliance for Genomics and Health, Toronto, Ontario, Canada.
  • Kato K; Partners HealthCare Laboratory for Molecular Medicine and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Knoppers B; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Markello C; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
  • Nussbaum R; Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Offit K; Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University, Montreal, Québec, Canada.
  • Plon SE; University of California Santa Cruz Genomics Institute, University of California, Santa Cruz, California, United States of America.
  • Rashbass J; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
  • Rehm HL; Center for Biomolecular Science & Engineering, University of California, Santa Cruz, California, United States of America.
  • Robson M; Invitae, San Francisco, California, United States of America.
  • Rubinstein WS; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Stoppa-Lyonnet D; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Tavtigian S; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Thorogood A; National Disease Registration, National Cancer Registration and Analysis Service, Public Health England, London, United Kingdom.
  • Zhang C; Laboratory for Molecular Medicine, Partners Healthcare Personalized Medicine, Cambridge, Massachusetts, United States of America.
  • Zimmermann M; Department of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Burn J; CancerLinQ at American Society of Clinical Oncology (ASCO), Alexandria, Virginia, United States of America.
  • Chanock S; Institut Curie, Cancer Genetic Clinic, Paris, France.
  • Rätsch G; Partners HealthCare Laboratory for Molecular Medicine and Harvard Medical School, Boston, Massachusetts, United States of America.
  • Spurdle AB; Department of Oncological Sciences, The University of Utah, Salt Lake City, Utah, United States of America.
PLoS Genet ; 14(12): e1007752, 2018 12.
Article em En | MEDLINE | ID: mdl-30586411
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genes BRCA1 / Genes BRCA2 / Bases de Dados Genéticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Genes BRCA1 / Genes BRCA2 / Bases de Dados Genéticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: PLoS Genet Assunto da revista: GENETICA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos